RxDoctor Payments Data

Melissa Hu, MD

Otolaryngology/Facial Plastic Surgery · Webster, TXNPI 1568639722

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $2,806 of the $3,265 with a category attached, or 85.9%. It is spread thinly across 20 manufacturers, the largest accounting for just 22.2% — the pattern of someone who eats at a lot of different presentations.

$3,265in general payments, 2019–2025

Across 115 payments — averaging $28.39 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Aerin Medical Inc.$726
  • Medical Device Business Services, Inc.$517
  • Revance Therapeutics, Inc.$515
  • Optinose US, Inc.$419
  • GSK$194
  • Galderma Laboratories, L.p.$145
  • plus $749 from 14 others

What the payments were for

  • Travel & lodging$45514%
  • Food & beverage$2,80686%
  • Gifts$40%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$3,265 in reported general payments places this provider in the 60th percentile of 51 otolaryngology/facial plastic surgery providers in Texas.

See all otolaryngology/facial plastic surgery providers in Texas

Medicare billing

Part B allowed, 2024
$99,168
Medicare patients
223
Services billed
624

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Ipratropium Bromide127$3,719
Ofloxacin35$1,332
Azelastine Hcl51$1,064
Fluticasone Propionate64$954
Levocetirizine Dihydrochloride84$937
Omeprazole21$309
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen15$279
Clotrimazole-BetamethasoneClotrimazole/Betamethasone Dip25$279
Methylprednisolone40$276
Cephalexin38$273
Ondansetron OdtOndansetron26$235
Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav23$217
Mupirocin23$210
Azithromycin21$122
ErythromycinErythromycin Base11$91

Paid to pharmacies, not to this prescriber.

Other otolaryngology/facial plastic surgery in Webster

See the full list for Texas

Where these figures come from

Is this you, or does something look wrong? →